Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Sep 19 - Sep 24
High-Throughput Virtual Screening Identifies Novel N'-(1-Phenylethylidene)-benzohydrazides as Potent
Mutant p53 as a therapeutic target for the treatment of triple-negative breast cancer: Preclinical investigation with the anti-p53 drug
In addition to cell growth
Smiles: CC(=O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@@]21C)OS(=O)(=O)O[Na]
CAS Number: 2093408-03-6
NMI 8739 Catalog No.:M16876-C High-Throughput Virtual Screening Identifies NovelNMI 8739 is a dopamine D2 autoreceptor agonist, which is an amine conjugate of the DHA carrier and the neurotransmitter dopamine. Product information CAS Number: 129024 87 9 Molecular Weight: 463. 65 Formula: C30H41NO3 Chemical Name: (4Z, 7Z, 10Z, 13Z, 16Z, 19Z) N (3, 4 dihydroxyphenethyl)docosa 4, 7, 10, 13, 16, 19 hexaenamide Smiles: CC C=C\C C=C\C C=C\C C=C\C C=C\C C=C\CCC(=O)NCCC1C=C(O)C(O)=CC=1 InChiKey: HXJMZRVSTICUKC KUBAVDMBSA N InChi:
US$ 550.00
US$ 2250.00
US$ 397.50
US$ 160.00
US$ 1897.50
US$ 287.50